迈瑞医疗收盘上涨2.79%，滚动市盈率25.25倍，总市值2811.65亿元

Group 1 - The core viewpoint of the articles highlights that Mindray Medical's stock closed at 231.9 yuan, with a 2.79% increase, and a rolling PE ratio of 25.25 times, while the total market capitalization reached 281.165 billion yuan [1] - In comparison to the medical device industry, which has an average PE ratio of 48.79 times and a median of 35.20 times, Mindray Medical ranks 57th in terms of PE ratio [1][2] - The latest financial performance indicates that for Q1 2025, the company reported a revenue of 8.237 billion yuan, a year-on-year decrease of 12.12%, and a net profit of 2.629 billion yuan, down 16.81%, with a gross profit margin of 62.53% [1] Group 2 - The main business of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. includes the research, manufacturing, marketing, and service of medical devices, with key products in life information and support, in vitro diagnostics, medical imaging, electrophysiology, and vascular intervention [1] - On May 23, the net outflow of main funds for Mindray Medical was 141.775 million yuan, indicating a trend of outflow over the past five days, totaling 4.0746 million yuan [1]